Navigation Links
Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves
Date:8/26/2011

than 50 years to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF) and is sold under the brand name Pradaxa®.(8) In the first eight months after approval, nearly 300,000 patients in the U.S. were prescribed PRADAXA.(9)  

"PRADAXA has almost a full year of clinical use for the reduction of stroke risk in patients with non-valvular atrial fibrillation," said Chris Barrett, senior vice president, marketing, Boehringer Ingelheim Pharmaceuticals, Inc. "We continue to see a steady growth in the number of patients treated with PRADAXA and are proud of the widespread formulary coverage that has been achieved, providing access to 90 percent of covered lives in the U.S."

Findings from the Phase III RE-LY® trial showed that PRADAXA 150mg taken twice daily significantly reduced stroke and systemic embolism by 35 percent beyond the reduction achieved with warfarin (dosed to international normalized ratio (INR) 2.0 to 3.0, mean time in therapeutic range = 64.4 percent)(8) in patients with NVAF.(8) Effects of PRADAXA were more apparent in patients with lower levels of INR control.(8)  Dabigatran is recommended in an update to atrial fibrillation treatment guidelines.  

About RE-LY

RE-LY was a global, Phase III, randomized trial of 18,113 patients(8) enrolled in 951 centers in 44 countries,(10) investigating whether dabigatran etexilate (two blinded doses) was as effective as well-controlled warfarin - INR 2.0 - 3.0 - (open label) for stroke prevention.(8)  Patients with non-valvular AFib and at least one other risk factor for stroke (i.e., previous ischemic stroke, transient ischemic attack, or systemic embolism, left ventricular dysfunction, age greater than or equal to 75 years, age greater than or equal to 65 years with either diabetes mellitus, history of coronary artery disease, or hypertension) were enrolled in the study for two years(8) with a minimum fol
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Boehringer Ingelheim and Ashokas Changemakers Launch "Making More Health" Competition
2. Ashoka and Boehringer Ingelheim Announce a Global Partnership for "Making More Health"
3. Zealand Pharma and Boehringer Ingelheim Enter Into a Licence and Collaboration Agreement to Advance Novel Compounds to Treat Type-2 Diabetes and Obesity
4. Boehringer Ingelheim to present new data at ASCO annual meeting regarding its investigational compound afatinib in EGFR-mutation positive patients with advanced NSCLC
5. Positive Phase 2 Results Reported with Boehringer Ingelheims Investigational HCV Protease Inhibitor in Both Previously Treated and Untreated Patients
6. Pfenex Inc. and Boehringer Ingelheim Announce Non-Exclusive Strategic Agreement for the Use of Pfenex Expression Technology™
7. Boehringer Ingelheim to Purchase Amgens Fremont (USA) Facility
8. Boehringer Ingelheim to Purchase Amgens Fremont (California) Facility
9. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
10. Boehringer Ingelheim Initiates Phase III Clinical Trial With Afatinib in Advanced Breast Cancer
11. Boehringer Ingelheims Pradaxa Available in U.S. Pharmacies Starting Wednesday, November 3
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 2014  Beamz Interactive, Inc. (OTCQB: BZIC), a ... announced that it has signed an agreement with ... of innovative prosthetic, orthotic and assistive technology products ... agreement, RSL Steeper will promote and supply the ... use within UK residential care facilities through its ...
(Date:12/17/2014)... , Dec. 17, 2014  IGI Laboratories, Inc. (NYSE ... closing of its offering of $125 million aggregate principal ... "Notes").  The Notes were offered and sold only to ... Securities Act of 1933, as amended (the "Securities Act"). ... rate of 3.75% per year, payable semiannually in arrears ...
(Date:12/17/2014)... 17, 2014 PCCA received the Autism ... http://bit.ly/1382OkS ) program seal for best practices in ... highlights medical practices, materials and goods that meet ... Children affected by autism often have unique ... by ingredients found in food and medicine – ...
Breaking Medicine Technology:Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 2Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 3
... 19, 2012 Uroplasty, Inc. (NASDAQ: UPI ) ... third quarter of fiscal 2012 ended December 31, 2011, at ... will host a conference call to discuss these results on ... p.m. Central Time). David Kaysen, President and Chief Executive Officer, ...
... MINNEAPOLIS, Jan. 19, 2012 /PRNewswire-iReach/ -- Today, ... the 4th Annual TripleTree iAwards for Wireless Health ... impactful mobile and wireless solutions in the healthcare industry. ... be accepted through March 30, 2012.  Each application will ...
Cached Medicine Technology:Uroplasty to Issue Third Quarter 2012 Financial Results on January 26, 2012 2Call for Submissions: 2012 TripleTree iAwards for Wireless Health 2Call for Submissions: 2012 TripleTree iAwards for Wireless Health 3
(Date:12/19/2014)... TX (PRWEB) December 19, 2014 ... a shifting, capital equipment market that is saturated ... impressive safety and efficacy as well as non-invasive ... they were first introduced to the healthcare market. ... the development of MRI safe technologies have greatly ...
(Date:12/19/2014)... 2014 From November 24, 2014, Siddhi ... the year 2014 in its Goa retreat . This ... the Indian winters, from November to March, Siddhi Yoga will ... of Arambol, Goa. The Goa training sessions will conclude in ... yoga teacher training, the 10th intake is also a ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 The ... ski club in Southern Vermont’s Deerfield Valley, announced today ... inspired by classic rock songs. , Three time ... with a private concert followed by a trail naming ... new trail names include: “I’m Alright” the theme song ...
(Date:12/19/2014)... Dotinga HealthDay Reporter ... including ibuprofen, might slightly reduce your risk of developing ... of ibuprofen (Advil, Motrin) and naproxen (Aleve) appear to ... 15 percent, the researchers concluded after reviewing nine prior ... sun exposure. These painkillers "have potential ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 Dr. Myo Nwe ... Weight Loss Diet of the Future” and co-founder of the ... her book, Dr. Nwe takes a broad look at the ... hold up under scientific scrutiny. On film and in television ... emphasized mostly toward the social aspects and played for basic ...
Breaking Medicine News(10 mins):Health News:Magnetic Resonance Imaging Systems Market Analysis and Forecast to 2020 Report at RnRMarketReserach.com 2Health News:Magnetic Resonance Imaging Systems Market Analysis and Forecast to 2020 Report at RnRMarketReserach.com 3Health News:Magnetic Resonance Imaging Systems Market Analysis and Forecast to 2020 Report at RnRMarketReserach.com 4Health News:Siddhi Yoga’s 10th intake of YTT started in Goa on November 24, 2014 2Health News:Siddhi Yoga’s 10th intake of YTT started in Goa on November 24, 2014 3Health News:The Hermitage Club Officially Names Four Ski Trails after Iconic Rock Songs by Grammy Award Winner Kenny Loggins 2Health News:Common Painkillers May Help Prevent Certain Skin Cancers, Study Finds 2Health News:Common Painkillers May Help Prevent Certain Skin Cancers, Study Finds 3Health News:Obesity Should Not Be a Hollywood Punchline, Weight Loss Doc Says 2
... OAK BROOK, Ill. April 25, 2011 A ... acid suppression is a safe and effective method to ... adenocarcinoma (cancer) or high-grade dysplasia of the esophagus developed ... largest published series and longest follow-up of patients with ...
... , MONDAY, April 25 (HealthDay News) -- Some college students ... reruns during the TV writers, strike of 2007-2008, a new ... use television for companionship -- as opposed to simply for ... characters on the tube, the study authors noted. "We ...
... R.I. [Brown University] A new study of sexual ... that HIV-positive people take almost as much risk in ... HIV-negative or don,t know their status, as when they ... time, HIV-positive partners who are on antiretroviral therapy and ...
... Ga. Decreasing blood levels of a protein that ... could help children avoid type 1 diabetes, researchers say. ... levels of interleukin-1 receptor antagonist, or IL-1ra, in children ... risk for type 1 diabetes. They also are looking ...
... Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: ... Food and Drug Administration (FDA) has granted licensure to ... (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria ... infants and children 9 months through 23 months of ...
... MONDAY, April 25 (HealthDay News) -- Acupuncture might help ... patients while they,re on hormone therapy, a small study ... ancient Chinese discipline relieves hot flashes, and only 14 ... researchers at New York Methodist Hospital and Weill Cornell ...
Cached Medicine News:Health News:Long-term follow-up shows multipolar electrocoagulation ablation effective for Barrett's esophagus 2Health News:Long-term follow-up shows multipolar electrocoagulation ablation effective for Barrett's esophagus 3Health News:Long-term follow-up shows multipolar electrocoagulation ablation effective for Barrett's esophagus 4Health News:Some TV Fans 'Distressed' Without Favorite Shows: Study 2Health News:Fighting HIV in South Africa should focus on couples, study finds 2Health News:Fighting HIV in South Africa should focus on couples, study finds 3Health News:Protein levels could signal that a child will develop diabetes 2Health News:Sanofi Pasteur announces FDA approval of menactra meningococcal conjugate vaccine indication for infants 2Health News:Acupuncture May Help Ease Hot Flashes Tied to Prostate Cancer Treatment 2
Lacrimal Cannula, Curved - Closed End, CurvedSize: 25g x 1-1/2"....
PremierEdge™ Slit Knives....
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Medicine Products: